A small selective inhibitor of AURKA MLN8237 (Alisertib) suppressed NF-κB activity in human gastric cancer samples and mouse epithelial cells, and reduced expression of NF-κB target genes that regulate inflammation and cell survival. The gene discussed is NFKB1; the disease is gastric cancer.